Forward Pharma Operations ApS — Credit Rating and Financial Key Figures
Credit rating
Company information
About Forward Pharma Operations ApS
Forward Pharma Operations ApS (CVR number: 38757504) is a company from KØBENHAVN. The company reported a net sales of 0.1 mDKK in 2024, demonstrating a decline of -81.9 % compared to the previous year. The operating profit percentage was poor at -2273.4 % (EBIT: -2.3 mDKK), while net earnings were -68.3 mDKK. The profitability of the company measured by Return on Assets (ROA) was -20.9 %, which can be considered poor and Return on Equity (ROE) was -24.4 %, which can be considered poor. The equity ratio, a key indicator for solidity, stood at 80.1 %, a level that can be considered to be very good, which means that the majority of assets are financed by equity. Forward Pharma Operations ApS's liquidity measured by quick ratio was 5 which is at a very high level. Thus, the company demonstrates exceptional financial stability, possessing a significant surplus of liquid assets over its short-term liabilities.
Financial information
See financialsNet sales (kDKK)
EBIT (kDKK)
Profitability
Solidity
Key figures (kDKK)
See financials2020 | 2021 | 2022 | 2023 | 2024 | |
---|---|---|---|---|---|
Volume | |||||
Net sales | 351.02 | 621.56 | 724.02 | 546.95 | 99.13 |
Gross profit | -8 158.31 | -9 004.41 | -7 895.22 | -2 341.60 | -2 253.59 |
EBIT | -8 158.31 | -9 004.41 | -7 895.22 | -2 341.60 | -2 253.59 |
Net earnings | -10 108.94 | -9 486.97 | -27 022.41 | 1 043.21 | -68 343.76 |
Shareholders equity total | 314 592.32 | 305 105.35 | 278 082.93 | 279 126.14 | 280 041.15 |
Balance sheet total (assets) | 337 159.16 | 327 106.72 | 305 108.79 | 302 113.74 | 349 446.71 |
Net debt | - 199 538.71 | - 188 692.05 | - 179 998.75 | -1 914.04 | 64 400.94 |
Profitability | |||||
EBIT-% | -2324.1 % | -1448.7 % | -1090.5 % | -428.1 % | -2273.4 % |
ROA | -2.1 % | -2.3 % | -8.3 % | 0.5 % | -20.9 % |
ROE | -3.2 % | -3.1 % | -9.3 % | 0.4 % | -24.4 % |
ROI | -2.1 % | -2.3 % | -8.3 % | 0.5 % | -20.9 % |
Economic value added (EVA) | -25 570.01 | -25 942.19 | -24 329.15 | -17 653.19 | -17 350.76 |
Solvency | |||||
Equity ratio | 93.3 % | 93.3 % | 91.1 % | 92.4 % | 80.1 % |
Gearing | 7.1 % | 7.2 % | 9.6 % | 8.0 % | 24.7 % |
Relative net indebtedness % | -56819.4 % | -30347.7 % | -24805.7 % | -248.9 % | 65116.2 % |
Liquidity | |||||
Quick ratio | 14.1 | 14.0 | 11.3 | 13.1 | 5.0 |
Current ratio | 14.1 | 14.0 | 11.3 | 13.1 | 5.0 |
Cash and cash equivalents | 222 016.51 | 210 630.06 | 206 623.93 | 24 348.84 | 4 857.83 |
Capital use efficiency | |||||
Trade debtors turnover (days) | |||||
Net working capital % | 84080.3 % | 45959.7 % | 38402.8 % | 51033.0 % | 282507.4 % |
Credit risk | |||||
Credit rating | BBB | BBB | BBB | BB | BB |
Variable visualization
Companies in the same industry
- Professional credit risk reports
- Create your own estimates for any company
- Valuation analysis
- All 400,000+ Danish companies
- See instructions

... and more!
No registration needed.